Lee M - Search Results

1

Pulmonary delivery of a recombinant RAGE antagonist peptide derived from high-mobility group box-1 in a bleomycin-induced pulmonary fibrosis animal model.

Piao C, Zhuang C, Ko MK, Hwang DW, Lee M. Piao C, et al. Among authors: lee m. J Drug Target. 2022 Aug;30(7):792-799. doi: 10.1080/1061186X.2022.2069781. Epub 2022 Jun 13. J Drug Target. 2022. PMID: 35451894

2

DNA delivery to the mitochondria sites using mitochondrial leader peptide conjugated polyethylenimine.

Lee M, Choi JS, Choi MJ, Pak YK, Rhee BD, Ko KS. Lee M, et al. J Drug Target. 2007 Feb;15(2):115-22. doi: 10.1080/10611860600953555. J Drug Target. 2007. PMID: 17365282

3

Delivery of hypoxia-inducible VEGF gene to rat islets using polyethylenimine.

Kim HA, Lee BW, Kang D, Kim JH, Ihm SH, Lee M. Kim HA, et al. Among authors: lee bw, lee m. J Drug Target. 2009 Jan;17(1):1-9. doi: 10.1080/10611860802392982. J Drug Target. 2009. PMID: 19107668

4

Enhanced protection of Ins-1 beta cells from apoptosis under hypoxia by delivery of DNA encoding secretion signal peptide-linked exendin-4.

Ah Kim H, Lee S, Park JH, Lee S, Lee BW, Ihm SH, Kim TI, Kim SW, Ko KS, Lee M. Ah Kim H, et al. Among authors: lee bw, lee m, lee s. J Drug Target. 2009 Apr;17(3):242-8. doi: 10.1080/10611860902718664. J Drug Target. 2009. PMID: 19558363

5

Combinational therapy of ischemic brain stroke by delivery of heme oxygenase-1 gene and dexamethasone.

Hyun H, Lee J, Hwang DW, Kim S, Hyun DK, Choi JS, Lee JK, Lee M. Hyun H, et al. Among authors: lee j, lee m, lee jk. Biomaterials. 2011 Jan;32(1):306-15. doi: 10.1016/j.biomaterials.2010.08.116. Biomaterials. 2011. PMID: 20888632

6

Lung epithelial binding peptide-linked high mobility group box-1 A box for lung epithelial cell-specific delivery of DNA.

Kim HA, Park JH, Cho SH, Lee M. Kim HA, et al. Among authors: lee m. J Drug Target. 2011 Aug;19(7):589-96. doi: 10.3109/1061186X.2010.547584. Epub 2011 Feb 10. J Drug Target. 2011. PMID: 21309682

7

VEGF receptor binding peptide-linked amphiphilic peptide with arginines and valines for endothelial cell-specific gene delivery.

Ryu DW, Kim HA, Kim S, Lee M. Ryu DW, et al. Among authors: lee m. J Drug Target. 2012 Aug;20(7):574-81. doi: 10.3109/1061186X.2012.697166. Epub 2012 Jun 11. J Drug Target. 2012. PMID: 22686293

8

Post-translational regulation of gene expression using the ATF4 oxygen-dependent degradation domain for hypoxia-specific gene therapy.

Cho SH, Oh B, Kim HA, Park JH, Lee M. Cho SH, et al. Among authors: lee m. J Drug Target. 2013 Nov;21(9):830-6. doi: 10.3109/1061186X.2013.829073. Epub 2013 Aug 19. J Drug Target. 2013. PMID: 23952904

9

Combined delivery of BCNU and VEGF siRNA using amphiphilic peptides for glioblastoma.

Yi N, Oh B, Kim HA, Lee M. Yi N, et al. Among authors: lee m. J Drug Target. 2014 Feb;22(2):156-64. doi: 10.3109/1061186X.2013.850502. Epub 2013 Nov 13. J Drug Target. 2014. PMID: 24219243

10

Combination of TAT-HMGB1A and R3V6 amphiphilic peptide for plasmid DNA delivery with anti-inflammatory effect.

Kim B, Song JH, Lee M. Kim B, et al. Among authors: lee m. J Drug Target. 2014 Sep;22(8):739-47. doi: 10.3109/1061186X.2014.916711. Epub 2014 May 15. J Drug Target. 2014. PMID: 24830301

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45,901 results

Search Page

Filters